Basil Drugs Private Limited

Basil Drugs Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U24232MP2001PTC014624 Incorporated 16 April 2001 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2016
₹1.16 Cr
▲ 5% YoY
Net profit · FY 2016
₹1.09 Lakh
Net margin 0.9%
EBITDA · FY 2016
₹4.49 Lakh
EBITDA margin 3.9%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹6.83 Lakh
Secured borrowings
Company age
25 yrs
Est. 2001
Directors on board
3
As per MCA filings

About Basil Drugs Private Limited

Data last updated:

Basil Drugs Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 April 2001 and has been in existence for over 25 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP2001PTC014624. Its GSTIN is 23AACCB2576R1ZB (Madhya Pradesh).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was formerly known as Basil Drugs Limited. It is led by directors including Rajesh Kumar Singh (Managing Director) and Tara Kushwaha (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at N – 60 Anoop Nagar, Indore, Madhya Pradesh, India – 452011.

As per the financials filed for FY 2016, the company reported a revenue of ₹1.16 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹1.09 Lakh (net margin 0.9%) and EBITDA of ₹4.49 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 13% over five years.

As per MCA filings, the company has open charges of ₹6.83 Lakh on record.

Basil Drugs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0031366). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24232MP2001PTC014624
Registration Number 014624
Incorporation Date 16 April 2001
ROC Gwalior
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MP-23-0031366

CIN history

Basil Drugs has one previous CIN (Corporate Identification Number): U24232MP2001PLC014624. The current CIN is U24232MP2001PTC014624, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232MP2001PTC014624Current
U24232MP2001PLC014624Previous

Recognitions & Rankings of Basil Drugs

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MP-23-0031366

Contact details

Basil Drugs Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    N – 60 Anoop Nagar, Indore, Madhya Pradesh, India – 452011
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Basil Drugs Private Limited, buy the company report.

Comprehensive company report
Basil Drugs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Basil Drugs Private Limited

FY 2025 filings available

Basil Drugs Private Limited reported revenue of ₹1.16 Cr (up 5% YoY) for FY 2016.

Revenue · FY 2016
₹1.16 Cr ▲ 5%
Net profit · FY 2016
₹1.09 Lakh margin 0.9%
EBITDA · FY 2016
₹4.49 Lakh margin 3.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 9%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▼ 10%
3 years · compounded
▲ 2%
5 years · compounded
▲ 3%

Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 5% growth in the latest year. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹1.16 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.49 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.09 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2015-16FY 2014-15
Profitability
EBITDA Margin3.9%
Net Profit Margin0.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Basil Drugs Private Limited, buy the company report.

Board of directors of Basil Drugs Private Limited

Basil Drugs has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rajesh Kumar SinghManaging Director16 Apr 200125 Years 7 MonthsCurrent
Tara KushwahaWhole-Time Director16 Apr 200125 Years 7 MonthsCurrent
Mohammad Shakil SheikhWhole-Time Director30 Sep 200719 Years 1 MonthsCurrent

Auditor

Basil Drugs Private Limited is audited by A GATTANI & ASSOCIATES for the financial year 2016.

Auditor firmFinancial yearFirm registration number
A GATTANI & ASSOCIATESFY 2016003521C

Shareholding

The shareholding of Basil Drugs Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Basil Drugs Private Limited, buy the company report.

Charges & borrowings

Open charges
₹6.83 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.03 Cr
Icici Bank Limited₹0.02 Cr
State Bank of Indore₹0.02 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
13 Aug 2018100207896Others₹2.58 LakhOpen
18 Dec 201510620077Icici Bank Limited₹2.25 LakhOpen
17 Oct 200190203856State Bank of Indore₹2 LakhOpen

To see the full charge records of Basil Drugs Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Basil Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Basil Drugs has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
23AACCB2576R1ZBMadhya PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Basil Drugs Private Limited, buy the company report.

Recent activity

Basil Drugs Private Limited has 7 board changes on record since 2001: 3 appointments and 4 cessations. The latest: Mohammad Shakil Sheikh ceased to be Director on 01 Oct 2013.

AGM
Basil Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Basil Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Others amounted to Rs. 2.58 Lakh with Charge ID 100207896 was registered on 13 Aug 2018.
Charges
A charge with Icici Bank Limited amounted to Rs. 2.25 Lakh with Charge ID 10620077 was registered on 18 Dec 2015.
Ceased
Mohammad Shakil Sheikh ceased to be Director.
Ceased
Rajesh Kumar Singh ceased to be Director.
Ceased
Tara Kushwaha ceased to be Director.
Ceased
Manish Kumar Jain ceased to be Director.
Appointed
Mohammad Shakil Sheikh was appointed as Whole-Time Director.
Charges
A charge with State Bank Of Indore of Rs. 2.00 Lakh registered on 17 Oct 2001 with Charge ID 90203856 was modified on 10 Nov 2004.
Charges
A charge with State Bank Of Indore amounted to Rs. 2.00 Lakh with Charge ID 90203856 was registered on 17 Oct 2001.
Appointed
Rajesh Kumar Singh was appointed as Managing Director.

2 earlier events are in the company report.

Frequently asked questions

Basil Drugs is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 April 2001 (25+ years old) and is registered under CIN U24232MP2001PTC014624.

Basil Drugs has 3 current directors:

The latest financial statements of Basil Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Basil Drugs is 23AACCB2576R1ZB, registered in Madhya Pradesh.

The CIN (Corporate Identification Number) of Basil Drugs is U24232MP2001PTC014624. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Basil Drugs was incorporated on 16 April 2001, making it 25+ years old. It is registered with the Registrar of Companies, Gwalior.

Mohammad Shakil Sheikh ceased to be Director on 01 Oct 2013. Rajesh Kumar Singh ceased to be Director on 01 Oct 2013. Tara Kushwaha ceased to be Director on 01 Oct 2013. Basil Drugs has 7 board changes on record in total.

Yes, Basil Drugs is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0031366).

The registered office of Basil Drugs is at N – 60 Anoop Nagar, Indore, Madhya Pradesh, India – 452011.

Basil Drugs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.